Tutanota LLC Extends Tender Offer for up to 500,000 Shares of Common Stock of Bristol-Myers Squibb Company
Nyenta.com/10270011

NEW YORK - Nyenta -- Tutanota LLC ("Purchaser") announces that its previously-announced tender offer (the "Offer") to acquire up to 500,000 shares of common stock (the "Shares") of Bristol-Myers Squibb Company for $55.00 per Share (the "Offer Price"), less applicable dividends, has been extended to 5:00 p.m., New York City time, on Friday, September 6, 2024, unless further extended or earlier terminated (the "Expiration Date"). The Offer was previously scheduled to expire at 5:00 p.m., New York City time, on Friday, February 23, 2024. All other terms and conditions of the Offer remain unchanged.

Shareholders who have already tendered their Shares do not have to re-tender their Shares or take any other action due to extension of the Offer's expiration date.

The Offer is subject to closing conditions set forth in the Offer to Purchase, dated January 22, 2024, including the closing price of the Shares on the NYSE on the last full trading day prior to the Expiration Date exceeding the Offer Price and Purchaser obtaining financing necessary to fund Purchaser's financial obligations arising from the Offer.

More on Nyenta.com

• Guests Can Save 15 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Advance Purchase Discount'
• Tishman Speyer and NPS Celebrate Opening of New Office in Jeonju, South Korea
• Yonkers Mayor Spano Appoints Hope Hollinsworth-Coaxum Director of the Office of Constituent Services
• Elevate Local Launches to Help Tennessee Small Businesses Grow Online with Expert SEO and Digital Marketing
• BookCAMP 2025: The Trade Show for Independent Authors and Publishers

This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell shares or any other securities. The Offer to Purchase common stock of Bristol-Myers Squibb Company is only being made pursuant to the Offer to Purchase and Letter of Transmittal with respect to the Offer, as such documents may be supplemented and amended from time to time. Shareholders are urged to read these materials carefully because they contain important information, included the terms and conditions of the Offer, that shareholders should consider before making any decision regarding tendering their Shares. Shareholders can obtain a copy of the Offer to Purchase and Letter of Transmittal with respect to the Offer by contacting the information agent at (888) 519-8569 OR CONTACT@INFO-AGENT.COM. Copies of these materials and any documentation relating to the Offer are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from any jurisdiction where to do so would be unlawful.

More on Nyenta.com

• Creep by Radiohead Guitar Chord Tutorial Now Available
• Olga Torres Once Again Recognized as a Top Advisor by Foreign Investment Watch
• $300 Million in Milestones; Double-Digit Royalties; Neurospa LOI for Expansion of International Psychiatry Clinics plus NDA Filed with FDA on New Drug
• Rosann Santos Becomes Licensed Speaker with Impostor Syndrome Institute to Offer Rethinking Impostor Syndrome™ Program
• COSRX Offers Unmissable Deals in Amazon's Big Spring Sale 2025

Tutanota LLC is a private investment company that specializes in investing in publicly traded securities.

Forward Looking Statements

Statements included in this press release that are not historical facts are forward-looking statements, which involve a number of risks and uncertainties and are subject to change at any time.  While Purchaser may elect to update forward-looking statements in the future, Purchaser specifically disclaims any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.